Similar articles

• Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial).

  Serebruany VL. Serebruany VL. Am J Cardiol. 2008 Jun 15;101(12):1808-9. doi: 10.1016/j.amjcard.2008.02.084. Epub 2008 Apr 9. Am J Cardiol. 2008. PMID: 18549865 No abstract available.
• CORONA, statins, and heart failure: who lost the crown?

  Athyros VG, Kakafika AI, Tziomalos K, Karagiannis A, Mikhailidis DP. Athyros VG, et al. Angiology. 2008 Feb-Mar;59(1):5-8. doi: 10.1177/0003319707313882. Angiology. 2008. PMID: 18319216 No abstract available.
• Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.

  Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni AP, Marchioli R, Nicolosi GL, Porcu M; GISSI-HF Investigators. Tavazzi L, et al. Eur J Heart Fail. 2004 Aug;6(5):635-41. doi: 10.1016/j.ejheart.2004.03.001. Eur J Heart Fail. 2004. PMID: 15302013 Clinical Trial.
• Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.

  Ridker PM; JUPITER Study Group. Ridker PM, et al. Circulation. 2003 Nov 11;108(19):2292-7. doi: 10.1161/01.CIR.0000100688.17280.E6. Circulation. 2003. PMID: 14609996 Review. No abstract available.
• [The role of statins in the treatment of heart failure].

  Eren M. Eren M. Turk Kardiyol Dern Ars. 2009 Oct;37(7):501-11. Turk Kardiyol Dern Ars. 2009. PMID: 20098048 Review. Turkish.